These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 11090007)

  • 1. Factors affecting axillary lymph node metastases in patients with T1 breast carcinoma.
    Markopoulos C; Kouskos E; Gogas H; Mandas D; Kakisis J; Gogas J
    Am Surg; 2000 Nov; 66(11):1011-3. PubMed ID: 11090007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of axillary lymph node metastases in patients with T1 breast carcinoma.
    Barth A; Craig PH; Silverstein MJ
    Cancer; 1997 May; 79(10):1918-22. PubMed ID: 9149018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and predictors of axillary metastasis in T1 carcinoma of the breast.
    Giuliano AE; Barth AM; Spivack B; Beitsch PD; Evans SW
    J Am Coll Surg; 1996 Sep; 183(3):185-9. PubMed ID: 8784309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of tumor size and axillary lymph node involvement with prognosis in patients with T1 breast carcinoma.
    Abner AL; Collins L; Peiro G; Recht A; Come S; Shulman LN; Silver B; Nixon A; Harris JR; Schnitt SJ; Connolly JL
    Cancer; 1998 Dec; 83(12):2502-8. PubMed ID: 9874455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of axillary lymph node metastasis in T1 breast carcinoma.
    Shoup M; Malinzak L; Weisenberger J; Aranha GV
    Am Surg; 1999 Aug; 65(8):748-52; discussion 752-3. PubMed ID: 10432085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Axillary lymph node dissection in pT1 breast cancer: a retrospective analysis of 315 patients and review of the literature.
    Witt A; Obwegeser R; Auerbach L; Tempfer C; Yavuz D; Kubista E
    Wien Klin Wochenschr; 2002 Jun; 114(10-11):387-90. PubMed ID: 12708092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Axillary lymph node dissection in breast cancer: an evolving question?
    Lagares-Garcia JA; Garguilo G; Kurek S; LeBlond G; Diaz F
    Am Surg; 2000 Jan; 66(1):66-72. PubMed ID: 10651351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Axillary lymph node status of T1 primary breast cancer in a diverse population.
    Madan AK; Macareo L; Winfrey K; Beech DJ
    Am Surg; 2001 Jan; 67(1):71-4. PubMed ID: 11206902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Axillary lymph node dissection: is it required in T1a breast cancer?
    Chontos AJ; Maher DP; Ratzer ER; Fenoglio ME
    J Am Coll Surg; 1997 May; 184(5):493-8. PubMed ID: 9145070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive factors associated with axillary lymph node metastases in T1a and T1b breast carcinomas: analysis in more than 900 patients.
    Rivadeneira DE; Simmons RM; Christos PJ; Hanna K; Daly JM; Osborne MP
    J Am Coll Surg; 2000 Jul; 191(1):1-6; discussion 6-8. PubMed ID: 10898177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective or routine axillary disease staging for patients with clinically lymph node-negative breast cancer?
    Hieken TJ; Velasco JM
    Surgery; 2006 Oct; 140(4):500-7; discussion 507-8. PubMed ID: 17011896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T1a and T1b breast cancer: a twelve-year experience.
    Visser TJ; Haan M; Keidan R; Lucas R; Ingold J; Glover J; Riggo P
    Am Surg; 1997 Jul; 63(7):621-6. PubMed ID: 9202537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Management of the axilla in breast cancer: evidences and unresolved issues].
    Fodor J; Polgár C; Péley G; Németh G
    Orv Hetil; 2001 Sep; 142(36):1941-50. PubMed ID: 11680099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Axillary lymph node metastases associated with small invasive breast carcinomas.
    Maibenco DC; Weiss LK; Pawlish KS; Severson RK
    Cancer; 1999 Apr; 85(7):1530-6. PubMed ID: 10193943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The incidence and significance of micrometastases in lymph nodes of patients with ductal carcinoma in situ and T1a carcinoma of the breast.
    Broekhuizen LN; Wijsman JH; Peterse JL; Rutgers EJ
    Eur J Surg Oncol; 2006 Jun; 32(5):502-6. PubMed ID: 16569492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy.
    Kim KJ; Huh SJ; Yang JH; Park W; Nam SJ; Kim JH; Lee JH; Kang SS; Lee JE; Kang MK; Park YJ; Nam HR
    Jpn J Clin Oncol; 2005 Mar; 35(3):126-33. PubMed ID: 15741302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
    Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
    Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of additional axillary metastasis of breast cancer following sentinel lymph node surgery.
    Changsri C; Prakash S; Sandweiss L; Bose S
    Breast J; 2004; 10(5):392-7. PubMed ID: 15327491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy.
    Truong PT; Olivotto IA; Kader HA; Panades M; Speers CH; Berthelet E
    Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1337-47. PubMed ID: 15817335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.